Dissemination (Meeting Coverage)

In individuals with multiple sclerosis (MS), researchers sought to determine the role of cognitive dysfunction in motor disability and structural disease-related burden. About 81 healthy controls and 109 relapsing-remitting (RR)...

In the OPTIMUM trial, researchers sought to determine disability, cognition, motor function, and multiple sclerosis (MS) fatigue in relation to baseline and change in brain volume (BV). Over the course of 108 weeks, patients...

For a study, the researchers sought to look at early-stage relapsing-remitting multiple sclerosis (RRMS) patients’ long-term prognosis (LTP) communication preferences and factors. A non-interventional, multicenter trial...

For a study, the researchers sought to determine the safety and tolerability of a ketogenic diet (KD) in relapsing MS patients and the influence on patient-reported, laboratory, and clinical outcome measures. Investigators...

No evidence of disease activity 3 and 4 (NEDA-3 and NEDA-4) in RMS patients treated with ozanimod were evaluated. Data were gathered from a randomized phase 3 trial (RADIANCE, NCT02047734) comparing oral ozanimod 0.92 mg/d to...

The researchers evaluated the size and duration of interferon-induced changes in cortical grey matter volume (CGMV) for a study. In addition, they examined the long-term effects of switching to ozanimod in relapsing multiple...

For a study, the researchers sought to characterize antibody and T-cell responses to the 3 SARS-CoV-2 vaccinations now available in the United States (US) in patients with relapsed multiple sclerosis (RMS) who were using...

For a study, the researchers sought to assess FBLN2 expression in MS and EAE lesions to see if the ECM molecule could alter oligodendrocyte maturation and remyelination. The study team discovered elevated levels of FBLN2 in EAE...

The researchers sought to examine aging-related mechanisms in MS prognosis for a study. They also sought to determine sex-specific elements that influence MS prognosis and explore the link between sex, hormones, and aging in MS...

For a study, the researchers sought to undertake 2 analyses. They combined EHR data with gold-standard data from a well-established clinic-based research registry. First, they used a 2-stage process to develop models that...

For a study, the researchers sought to compare the cognitive effects of active vs sham tDCS combined with adaptive cognitive training (aCT) administered as an at-home intervention in adults with MS in a randomized...

For a study, the researchers examined the relationship between sNfL levels throughout a 2-year period and clinical disability and gray matter (GM) atrophy after 10 years in early relapsing-remitting MS (RRMS) patients. A total...

For a study, the researchers sought to forecast the conditional average treatment effect (CATE) for people on anti-CD20 monoclonal antibodies and laquinimod for a study. For this, researchers used a multitask multilayer...

SARS-CoV-2 induced Coronavirus Disease 19 (COVD-19), a highly transmissible and potentially lethal illness, became a global pandemic in early 2020. Several vaccinations against this virus have been developed, including 2 novel...

For a study, the researchers sought to see if early serum neurofilament light (sNfL) and glial fibrillary acidic protein (sGFAP) levels, assessed at baseline and 1 year later, provide predictive value to models of commonly...

Patients with severe multiple sclerosis (MS) were increasingly receiving autologous hematopoietic stem cell transplantation (aHSCT). For a study, the researchers sought to look at the short and long-term results after aHSCT in...

In patients with multiple sclerosis (MS), cognitive dysfunction particularly slowed cognitive processing speed (CPS), was a key source of disability. Compared to intramuscular interferon (IFN) Beta-1a, the sphingosine...